Host: |
Rabbit |
Applications: |
WB/ELISA |
Reactivity: |
Human/Mouse |
Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
Clonality: |
Polyclonal |
Conjugation: |
Unconjugated |
Isotype: |
IgG |
Formulation: |
PBS with 0.02% Sodium Azide, 50% Glycerol, pH 7.3. |
Purification: |
Affinity purification |
Concentration: |
Lot specific |
Dilution Range: |
WB:1:200-1:1000ELISA:Recommended starting concentration is 1 Mu g/mL. Please optimize the concentration based on your specific assay requirements. |
Storage Instruction: |
Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles. |
Gene Symbol: |
PTPRJ |
Gene ID: |
5795 |
Uniprot ID: |
PTPRJ_HUMAN |
Immunogen Region: |
140-370 |
Specificity: |
Recombinant fusion protein containing a sequence corresponding to amino acids 140-370 of human PTPRJ (NP_002834.3). |
Immunogen Sequence: |
KSNDTAASEYKYVVKHKMEN EKTITVVHQPWCNITGLRPA TSYVFSITPGIGNETWGDPR VIKVITEPIPVSDLRVALTG VRKAALSWSNGNGTASCRVL LESIGSHEELTQDSRLQVNI SGLKPGVQYNINPYLLQSNK TKGDPLGTEGGLDASNTERS RAGSPTAPVHDESLVGPVDP SSGQQSRDTEVLLVGLEPGT RYNATVYSQAANGTEGQPQA IEFRTNAIQVF |
Tissue Specificity | Expressed in the promyelocytic cell line HL-60, the granulocyte-macrophage colony-stimulating factor-dependent leukemic cell line F-36P, and the IL3 and erythropoietin-dependent leukemic cell line F-36E. Expressed predominantly in epithelial cells and lymphocytes. Enhanced expression at high cell density. Isoform 2: Expressed in the brain. |
Post Translational Modifications | N- and O-glycosylated. Isoform 2: N-glycosylated. |
Function | Tyrosine phosphatase which dephosphorylates or contributes to the dephosphorylation of CTNND1, FLT3, PDGFRB, MET, KDR, LYN, SRC, MAPK1, MAPK3, EGFR, TJP1, OCLN, PIK3R1 and PIK3R2. Plays a role in cell adhesion, migration, proliferation and differentiation. Has a role in megakaryocytes and platelet formation. Involved in vascular development. Regulator of macrophage adhesion and spreading. Positively affects cell-matrix adhesion. Positive regulator of platelet activation and thrombosis. Negative regulator of cell proliferation. Negative regulator of PDGF-stimulated cell migration.through dephosphorylation of PDGFR. Positive regulator of endothelial cell survival, as well as of VEGF-induced SRC and AKT activation.through KDR dephosphorylation. Negative regulator of EGFR signaling pathway.through EGFR dephosphorylation. Enhances the barrier function of epithelial junctions during reassembly. Negatively regulates T-cell receptor (TCR) signaling. Upon T-cell TCR activation, it is up-regulated and excluded from the immunological synapses, while upon T-cell-antigen presenting cells (APC) disengagement, it is no longer excluded and can dephosphorylate PLCG1 and LAT to down-regulate prolongation of signaling. Isoform 2: Activates angiogenesis and cell migration. Downregulates the expression of the endothelial adhesion molecules ICAM1 and VCAM1. |
Protein Name | Receptor-Type Tyrosine-Protein Phosphatase EtaProtein-Tyrosine Phosphatase EtaR-Ptp-EtaDensity-Enhanced Phosphatase 1Dep-1Hptp EtaProtein-Tyrosine Phosphatase Receptor Type JR-Ptp-JCd Antigen Cd148 |
Database Links | Reactome: R-HSA-202427Reactome: R-HSA-6798695Reactome: R-HSA-6807004Reactome: R-HSA-9706369 |
Cellular Localisation | Cell MembraneSingle-Pass Type I Membrane ProteinCell ProjectionRuffle MembraneCell JunctionAfter T-Cell StimulationIt Is Temporarily Excluded From Immunological SynapsesIsoform 2: SecretedExtracellular Space |
Alternative Antibody Names | Anti-Receptor-Type Tyrosine-Protein Phosphatase Eta antibodyAnti-Protein-Tyrosine Phosphatase Eta antibodyAnti-R-Ptp-Eta antibodyAnti-Density-Enhanced Phosphatase 1 antibodyAnti-Dep-1 antibodyAnti-Hptp Eta antibodyAnti-Protein-Tyrosine Phosphatase Receptor Type J antibodyAnti-R-Ptp-J antibodyAnti-Cd Antigen Cd148 antibodyAnti-PTPRJ antibodyAnti-DEP1 antibody |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance